|
||||||||||||||||||||||
|
|
Alternate Title Phase II Randomized Study of Inositol for the Prevention of Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
Trial Description Chemoprevention is the use of certain drugs to keep cancer from forming. The use of inositol may prevent lung cancer. It is not yet known whether inositol is more effective than a placebo in preventing lung cancer in smokers with bronchial dysplasia. This randomized phase II trial is studying inositol to see how well it works compared with a placebo in preventing lung cancer in current or former smokers with bronchial dysplasia Eligibility criteria include the following:
Final eligibility for a clinical trial is determined by the health professionals conducting the trial. Patients will be randomly assigned (have an equal chance of being placed) to one of two treatment groups. Patients in group one will receive inositol by mouth once a day for 2 weeks and then twice a day for up to 6 months. Patients in group two will receive a placebo by mouth once a day for 2 weeks and then twice a day for up to 6 months. Patients will undergo bronchoscopy with bronchial lavage, bronchial brushings, and biopsies, imaging procedures, and blood sample collection at the beginning of the study and after finishing treatment for laboratory studies. After finishing treatment, patients will be evaluated within 1 month. Important: For more details about this trial, refer to the Health Professional version of the trial summary. If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site. Trial Lead Organizations Mayo Clinic Cancer Center
|
NCI Home |
Images Version |
Contact Us |
Policies |
Accessibility |
Viewing Files |
FOIA |
Site Help |
Site Map
|
A Service of the National Cancer Institute |